1. Home
  2. BIVI vs HFBL Comparison

BIVI vs HFBL Comparison

Compare BIVI & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • HFBL
  • Stock Information
  • Founded
  • BIVI 2013
  • HFBL 1924
  • Country
  • BIVI United States
  • HFBL United States
  • Employees
  • BIVI 14
  • HFBL N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • HFBL Savings Institutions
  • Sector
  • BIVI Health Care
  • HFBL Finance
  • Exchange
  • BIVI Nasdaq
  • HFBL Nasdaq
  • Market Cap
  • BIVI 18.8M
  • HFBL 41.8M
  • IPO Year
  • BIVI N/A
  • HFBL N/A
  • Fundamental
  • Price
  • BIVI $1.02
  • HFBL $12.31
  • Analyst Decision
  • BIVI Strong Buy
  • HFBL
  • Analyst Count
  • BIVI 1
  • HFBL 0
  • Target Price
  • BIVI $30.00
  • HFBL N/A
  • AVG Volume (30 Days)
  • BIVI 297.1K
  • HFBL 2.0K
  • Earning Date
  • BIVI 05-13-2025
  • HFBL 04-25-2025
  • Dividend Yield
  • BIVI N/A
  • HFBL 4.22%
  • EPS Growth
  • BIVI N/A
  • HFBL N/A
  • EPS
  • BIVI N/A
  • HFBL 1.09
  • Revenue
  • BIVI N/A
  • HFBL $19,713,000.00
  • Revenue This Year
  • BIVI N/A
  • HFBL N/A
  • Revenue Next Year
  • BIVI N/A
  • HFBL N/A
  • P/E Ratio
  • BIVI N/A
  • HFBL $11.31
  • Revenue Growth
  • BIVI N/A
  • HFBL N/A
  • 52 Week Low
  • BIVI $0.99
  • HFBL $10.60
  • 52 Week High
  • BIVI $7.50
  • HFBL $14.08
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 23.10
  • HFBL 37.82
  • Support Level
  • BIVI $1.09
  • HFBL $12.35
  • Resistance Level
  • BIVI $1.24
  • HFBL $12.76
  • Average True Range (ATR)
  • BIVI 0.10
  • HFBL 0.15
  • MACD
  • BIVI -0.01
  • HFBL -0.08
  • Stochastic Oscillator
  • BIVI 6.67
  • HFBL 0.00

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About HFBL Home Federal Bancorp Inc. of Louisiana

Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.

Share on Social Networks: